Basics Lifecore Biomedical, Inc. IPO Date: March 1, 1996 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $285.87M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.91% Avg Daily Range (30 D): $0.17 | 2.31% Avg Daily Range (90 D): $0.16 | 2.23% Institutional Daily Volume Avg Daily Volume: .24M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .12M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 58 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 29 Avg Inst. Trade: $2.91M Avg Inst. Trade (30 D): $3.7M Avg Inst. Trade (90 D): $2.22M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.02M Avg Closing Trade (30 D): $3.7M Avg Closing Trade (90 D): $2.22M Avg Closing Volume: 687.46K     News Oct 13, 2025 @ 11:00 AM Lifecore Biomedical to Participate at Upcoming Ind... Source: Lifecore Biomedical, Inc. Sep 27, 2025 @ 12:31 PM LIFECORE INVESTIGATION ALERT: Bragar Eagel & Squir... Source: Bragar Eagel & Squire, P.C. Aug 15, 2025 @ 12:42 AM LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Inv... Source: Bragar Eagel & Squire, P.C. Jun 17, 2025 @ 11:00 AM Lifecore Biomedical Signs New 10-Year Commercial M... Source: N/A Jun 12, 2025 @ 11:00 AM Lifecore Biomedical Receives Accelerated Payment o... Source: N/A Financials   TTM Q4 2025 FY 2025 Basic EPS $-.29 $-.03 $-1.27 Diluted EPS $-.29 $-.03 $-1.27 Revenue $ 31.11M $ 36.44M $ 128.87M Gross Profit $ 7.79M $ 13.98M $ 40.3M Net Income / Loss $ -9.99M $ -1.15M $ -38.72M Operating Income / Loss $ -3.07M $ 5.33M $ -17.25M Cost of Revenue $ 23.32M $ 22.46M $ 88.57M Net Cash Flow $ -1.36M $ 2.85M $ -.2M PE Ratio